CALGARY, Nov. 2 /CNW/ - Novozymes Biologicals Holding A/S announced today
that it has filed its formal offer to acquire all the common shares of Philom
Bios Inc. with securities regulators in Canada, and has mailed its offering
circular and related documents to Philom Bios Inc. shareholders.
The offer will remain open until 12:01 a.m. (Calgary time) on
December 10, 2007, unless the offer is withdrawn or extended by Novozymes
Biologicals Holding A/S. Under the terms of the offer, Philom Bios Inc.
shareholders will be offered $6.50 for each Philom Bios Inc. common share.
The offer documents are available on www.sedar.com.
Novozymes is the world leader in bioinnovation. Together with customers
across a broad array of industries we create tomorrow's industrial
biosolutions, improving our customers' business and the use of our planet's
With over 700 products used in 130 countries, Novozymes' bioinnovations
improve industrial performance and safeguard the world's resources by offering
superior and sustainable solutions for tomorrow's ever-changing marketplace.
Read more at www.novozymes.com.
For further information:
For further information: Press and media: Annegrethe Jakobsen, Phone
(direct): +45 4446 3050, Phone (mobile): +45 3077 3050; Yokima Cureton, (North
America), Phone (direct): (919) 494-3209, Phone (mobile): (919) 218-4501;
Johan Melchior, Phone (direct): +45 4446 0690, Phone (mobile): +45 3077 0690;
Analysts and investors: Tobias Bjxrklund, (North America), Phone (direct):
(919) 494-3483, Phone (mobile): (919) 649-2565; Camilla Kinch Jensen, Phone
(direct): +454446 0852, Phone (mobile): +45 3077 0852; Ian Christensen, Phone
(direct): +45 4446 0341, Phone (mobile): +45 3077 0341